Haemodynamic effects of selective beta-adrenergic blockade during acute stage of myocardial infarction.
D000083:Acetanilides / Q000494:pharmacology / Q000627:therapeutic use; D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000494:pharmacology / Q000627:therapeutic use*; D001011:Aorta; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D010100:Oxygen / Q000097:blood; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use; D011651:Pulmonary Artery; D011652:Pulmonary Circulation; D014655:Vascular Resistance / Q000187:drug effects
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D002245:Carbon Dioxide; D010100:Oxygen